Form 4 for CTKB Cytek Biosciences, Inc.
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001209191-22-017206 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-08 | 2022-03-04 | CTKB | Barnett Valerie | GC | M - OptEx | $4.71 | +10.5K | 12.4K | +553% | +$49.5K |
| D | 2022-03-08 | 2022-03-04 | CTKB | Barnett Valerie | GC | M - OptEx | $0.00 | -10.5K | 122.8K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-04 | M | A | 10,500 | $4.71 | 12,400 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-04 | M | D | 10,500 | $0.00 | 122,830 | D | $4.71 · — to 2031-03-22 | 10,500 Common Stock | (F1) The shares subject to the option vest as follows: 25% of the shares subject to the option vests on January 19, 2022; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years. |